An Idiopathic Thrombocytopenic Purpura Responding to the Antithyroid Treatment in a Patient with Graves Opthalmopathy: A Case Report
Müge Ozsan *
Department of Endocrinology and Metabolism, Mustafa Kemal University, Medical School, 31001 Hatay, Turkey.
Abdülrahim Eren
Department of Endocrinology and Metabolism, Mustafa Kemal University, Medical School, 31001 Hatay, Turkey.
Hasan Kaya
Department of Endocrinology and Metabolism, Mustafa Kemal University, Medical School, 31001 Hatay, Turkey.
Fahri Bayram
Department of Endocrinology and Metabolism, Erciyes University, Medical School, 38030 Kayseri, Turkey.
İhsan Ustün
Department of Endocrinology and Metabolism, Mustafa Kemal University, Medical School, 31001 Hatay, Turkey.
Cumali Gökçe
Department of Endocrinology and Metabolism, Mustafa Kemal University, Medical School, 31001 Hatay, Turkey.
*Author to whom correspondence should be addressed.
Abstract
Autoimmune diseases may be related with the development of a secondary autoimmune disorder. We, herein, report a case (31 years old female) of idiopathic thrombocytopenic purpura responding to antithyroid treatment in a patient with Graves Opthalmopathy (GO). The relation between Idiopathic Thrombocytopenic Purpura (ITP) and Graves Disease (GD) is not well known. In the current case, recovery from hyperthyroidism by propylthiouracil (PTU) coincided with the platelet count improvement to a tolerable level. To the literature, this is the first case of GD-GO associated with ITP responding to antithyroid-PTU therapy.
Keywords: Graves’s opthalmopathy, thrombocytopenia, propylthiouracil